Bafilomycins (Figure 1 ), macrolide antibiotics with a 16-membered lactone ring as their defining structural scaffold, are produced by a variety of streptomycetes. [1] [2] [3] [4] [5] These macrolides exhibit a variety of biological activities, including antitumor, 6 antifungal, 7 antiparasitic 8 and immunosuppressant activities. 9 In particular, bafilomycin A1 is an extremely potent and specific inhibitor of the vacuolar ATPases 10 and has also been found to inhibit the release of b-amyloid 11 and mitogeninduced DNA synthesis. 12 These features provide only a few examples of biological activities that have drawn considerable interest to the bafilomycins.
In our on-going effort to search for new and biologically active secondary metabolites produced by actinomycetes from unexplored and underexplored ecological niches, [13] [14] [15] [16] an endophytic actinomycete Streptomyces sp. YIM56209 was isolated from a healthy stem of Drymaria cordata. Initial screening of the crude extract showed potent cytotoxicity against selected cancer cell lines as well as moderate inhibitory effect on prolactin (PRL)-initiated phosphorylation of ERK1/2 in MCF-7 breast cancer cells. Large-scale fermentation and subsequent fractionation of the crude extract led to the isolation of two new bafilomycins, named 9-hydroxybafilomycin D (1) and 29-hydroxybafilomycin D (2), together with nine known bafilomycins identified as bafilomycin D (3), 3 bafilomycin E (4), 3 bafilomycin A1 (5), 1 bafilomycin B1 (6), 1,7 bafilomycin B2 (7), 1 bafilomycin C1 (8), 1 bafilomycin C2 (9), 1 bafilomycin C1 amide (10) 17 and bafilomycin C2 amide (11) 17 (Figure 1 ). The structures of 1 and 2 were established by comprehensive spectroscopic analyses, whereas the structures of 3-11 were confirmed by comparing their 1 H and 13 C NMR data with those in the literature. We present herein the isolation, structural elucidation and bioactivity assessment of these new and known bafilomycins.
The ethyl acetate extract of the Streptomyces sp. YIM56209 culture was subjected to sequential silica gel and Sephadex LH-20 chromatography, followed by further purification with reversed-phase HPLC to give 11 bafilomycins (1-11) (Figure 1 Tables S1 and S2 ), the shift of the methylene carbon signal (d C 41.6 at C-9 of 3) to the oxygenated methine signal (d C 77.2 at C-9 of 1), together with its MS data, suggested that 1 was likely a C-9 hydroxylated congener of 3. This conclusion was further supported by gHMBC correlation of H-9 (d The extreme cytotoxicity of the bafilomycins has limited their practical utility as both molecular probes and potential therapeutics. We therefore assessed the cytotoxicity of the two new bafilomycin analogs (1 and 2) together with the nine known ones (3-11) using A-549 human lung adenocarcinoma and HT-29 human colorectal adenocarcinoma cancer cell lines. Although 3-11 exhibited potent cytoxicity in general, under the conditions tested, the two new analogs 1 and 2 are, on average, two to three orders of magnitude less toxic, a property that could potentially be explored for the utilities of bafilomycin family (Table 2) .
The ability of 5 to inhibit vacuolar-type H + -ATPases, resulting in reduced acidification of sorting endosomes and subsequent interference with post-internalization receptor trafficking, is wellestablished. 10, 18 In light of the links between trafficking and signal transduction for many receptors, 19 we attempted to probe the effect of 1-11 on phosphorylation of the mitogen-activated protein kinases, ERK1/2, initiated by two well-characterized breast cancer mitogens, PRL 20 and epidermal growth factor (EGF), 21 in the breast cancer cell line MCF-7. As summarized in Table 2 , the relative activities of bafilomycin family members in this assay differed substantially. None of the bafilomycins tested was able to reduce EGF-initiated signals, although 4 slightly amplified these signals. The relative lack of activity in this assay resembles the failure of bafilomycin to inhibit EGF signals to c-fos in fibroblasts, despite inhibition of EGF-induced mitosis. 12 In contrast, six of the analogs, 2, 3, 5, 6, 7 and 10, were able to reduce PRL-mediated signals to ERK1/2; 10 displayed optimum activity with an IC 50 of B12 mM. The relative specificity of bafilomycins for PRL signaling pathway inhibition, compared with EGF, may reflect differences in receptor trafficking or other biological actions of these compounds; the susceptibility of receptor trafficking to reduced acidification has been reported to vary among cell types. 22 In summary, we have isolated two new bafilomycin analogs, 9-hydroxybafilomycin D (1) and 29-hydroxy-bafilomycin D (2), together with nine known bafilomycin congeners (3-11) from fermentation culture of the endophyte actinomycete Streptomyces sp. YIM56209 (Figure 1 ). 
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Z Yu et al and NMR techniques. Hydroxylation at either the C-9 or C-29 positions of 3, both integral components of the 16-membered lactone scaffold, profoundly impacts the biological activity of 1 and 2 relative to 3, as well as other previously known bafilomycins. For example, 1 was found to be B5000 times less cytotoxic to A549 cells and B4000
times less toxic to HT-29 cells than 3, whereas 2 was found to be B3000 times less cytotoxic to A549 cells and B1500 times less toxic to HT-29 cells relative to 3. As the bafilomycins are unable to be used clinically because of their fatal toxicity, 10 this discovery opens a new path for the practical application of bafilomycins. Moreover, the ability to inhibit PRL-mediated signaling pathways may be useful as few reagents are available to probe the activities of this hormone/ cytokine in normal physiology and pathology, including breast cancer.
EXPERIMENTAL SECTION
Optical rotations were measured in CHCl 3 on a Perkin-Elmer 241 instrument (Perkin-Elmer, Waltham, MA, USA) at the sodium D line (589 nm). 1 H and 13 C NMR spectra were recorded at 25 1C on a Varian Unity Inova 500 instrument (Agilent Technologies, Inc., Santa Clara, CA, USA) operating at 500 MHz for 1 H and 125 MHz for 13 C nuclei. High-resolution mass spectral analyses were acquired on an IonSpec HiResMALDI FT-MS with a 7 T superconducting magnet (IonSpec, Inc., Lake Forest, CA, USA). Semi-preparative HPLC was performed on a Varian HPLC system with an Alltima C18 column (5 m, 10.0Â250 mm, Alltech Associates, Inc., Deerfield, IL, USA). Column chromatography was performed either on silica gel (230-400 mesh, Natland International, Research Triangle Park, NC, USA), or Sephadex LH-20 (Pharmacia, Kalamazoo, MI, USA). Chemical regents were purchased from Sigma-Aldrich Corporation (St Louis, MO, USA). The producing stain YIM56209 was isolated from a healthy stem of traditional Chinese medicinal plant D. cordata from Xishuangbanna, Yunnan, China, which was used to treat hepatitis and nephritis, and was identified as Streptomyces sp. using a polyphasic taxonomy approach. Pure strain was permanently stored in 50% glycerol at À80 1C. The fermentation medium consisted of 2.0 g yeast extract, 5.0 g malt extract and 2.0 g dextrose in 1.0 l Milli-Q water (Millipore Corporation, Billerica, MA, USA), pH 7.2. A three-stage fermentation procedure was adopted:
(1) seed culture in 10 ml medium at 28 1C for 4 days, (2) 1.0 ml of the resultant culture as inoculum to 50 ml medium in 250-ml Erlenmeyer flasks at 28 1C for 3 days and (3) 20 ml the resultant culture as inoculum to 400 ml medium in 2.0-l Erlenmeyer flasks at 28 1C for 7 days, all on a rotary shaker at 250 r.p.m.
A total of 9.6 l of fermentation culture was collected and extracted with ethyl acetate. The combined extracts were concentrated under reduced pressure to give the crude residue (3.1 g), which was subjected to silica gel chromatography eluted with a hexane-ethyl acetate gradient (0-100%). Six fractions, A-F, were monitored by TLC analysis and collected. Fraction E (103 mg) was further chromatographed over Sephadex LH-20 column and eluted with MeOH to give three subfractions E1-E3. Subfraction E2 was finally purified by semi-preparative HPLC to afford 1 (1.0 mg), 2 (1.9 mg), 4 (2.1 mg), 10 (1.5 mg), 8 (1.8 mg), 11 (2.1 mg) and 9 (2.4 mg). Similarly, 3 (11.3 mg) and 5 (9.8 mg) were obtained from fraction C (260 mg) and 6 (12.8 mg) and 7 (21.2 mg) were obtained from fraction D (271 mg). Experimental procedures for cytotoxicity and ERK1/2 phosphorylation assays as well as 1 H and 13 C NMR data and spectra for 1 and 2 are provided as Supplementary Information.
